To address the clinical significance of macrophage FOXO1 activity in the pathogenesis of hepatic inflammation and NASH, we determined hepatic FOXO1 expression in the liver of patients with NASH. This evidence concerns the gene FOXO1 and metabolic dysfunction-associated steatohepatitis.